MediBeacon
St Louis
About MediBeacon
MediBeacon is an optical diagnostic company providing clinicians with critical information that improve patient care. Its mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological diseases in the human population. Several product concepts in these areas are contained in the MediBeacon Intellectual Property (IP) portfolio. The product pipeline includes real-time kidney function monitoring, a huge leap forward in the world of nephrology. The clinical history and road to FDA and European approvals on this component of the MediBeacon pipeline as well as other developments related to the platform of fluorescent agents and their potential clinical application.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $91.4M
- Last round: Convertible Note (Jul 2022)
- Website: medibeacon.com
- Phone: (314) 269-5808
Industries & Categories
Biotechnology, Health Care, Medical Device, Real Time
Social Profiles
Canonical: https://fsome.com/organization/medibeacon-22150 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.